Corteva (NYSE:CTVA) Given New $96.00 Price Target at The Goldman Sachs Group

Corteva (NYSE:CTVA) had its target price lifted by The Goldman Sachs Group from $88.00 to $96.00 in a research note issued to investors on Tuesday morning,MarketScreener reports. The firm currently has a buy rating on the stock.

A number of other analysts also recently weighed in on the stock. Wall Street Zen downgraded shares of Corteva from a “buy” rating to a “hold” rating in a report on Saturday, February 7th. Deutsche Bank Aktiengesellschaft upped their price target on shares of Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a report on Thursday, February 5th. Zacks Research downgraded shares of Corteva from a “strong-buy” rating to a “hold” rating in a report on Friday, February 20th. Oppenheimer set a $86.00 price target on shares of Corteva in a report on Thursday, February 5th. Finally, Bank of America upped their price target on shares of Corteva from $80.00 to $82.00 and gave the stock a “buy” rating in a report on Thursday, January 8th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $83.95.

Corteva Stock Performance

Shares of Corteva stock opened at $82.98 on Tuesday. The company has a 50 day moving average of $79.10 and a 200-day moving average of $70.81. Corteva has a 1-year low of $58.58 and a 1-year high of $85.63. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The company has a market cap of $55.71 billion, a PE ratio of 52.52, a price-to-earnings-growth ratio of 2.85 and a beta of 0.68.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The company had revenue of $3.91 billion during the quarter, compared to the consensus estimate of $4.23 billion. During the same quarter in the prior year, the firm posted $0.32 EPS. The firm’s quarterly revenue was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities research analysts forecast that Corteva will post 2.96 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were given a $0.18 dividend. The ex-dividend date was Monday, March 2nd. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 45.57%.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 8,311 shares of the firm’s stock in a transaction that occurred on Friday, February 20th. The shares were sold at an average price of $76.55, for a total value of $636,207.05. Following the sale, the insider owned 8,090 shares in the company, valued at $619,289.50. This trade represents a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.15% of the stock is owned by corporate insiders.

Institutional Trading of Corteva

Hedge funds have recently added to or reduced their stakes in the stock. Brighton Jones LLC lifted its holdings in shares of Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the period. Woodline Partners LP lifted its holdings in shares of Corteva by 40.3% during the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock worth $3,645,000 after purchasing an additional 16,644 shares during the period. EverSource Wealth Advisors LLC lifted its holdings in shares of Corteva by 62.1% during the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock worth $191,000 after purchasing an additional 980 shares during the period. Cresset Asset Management LLC raised its position in Corteva by 2.6% during the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after purchasing an additional 181 shares during the last quarter. Finally, Jump Financial LLC acquired a new position in Corteva during the 2nd quarter worth about $1,464,000. Institutional investors and hedge funds own 81.54% of the company’s stock.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.